All Policies Include Coronavirus Cover
Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30
Coronavirus FAQs
Questions about cover for coronavirus? Read our FAQs and find out what our policies can do for you. If you would like to contact us, please note we are currently only available 09:00 to 17:30 Monday to Friday due to reduced operational capacity. Thank you.
04 November 2014 11:55
Experts have found that eribulin can extend the lives of women with aggressive forms of breast cancer by several months
Giving breast cancer patients a drug made from sea sponges can extend their lives by several months, according to a new study.
Researchers at the University of Leeds carried out two large-scale trials with more than 1,800 participants who had been diagnosed with metastatic breast cancer.
They found that the drug eribulin extended the women's survival by an average of more than two months.
Women who had advanced triple negative breast cancer - an aggressive form of the disease for which there are few treatment options - benefited the most from the drug, with their lifespans increasing by almost five months.
Those with HER2 negative breast cancer lived more than two months longer when given eribulin, it was found.
Martin Ledwick, head information nurse at Cancer Research UK, described the results as "encouraging" for those women whose cancers no longer respond to conventional treatments.
He said that eribulin is not a cure but an additional option to extend patients' lives - which could be "priceless" for the women and their families. It may give them the option to spend valuable time with their family and friends, or to embark on a holiday with the security provided by specialist travel insurance for cancer patients.
The drug was originally derived from Halichondria okadai, a sea sponge, although it is now produced in laboratories.
Chris Twelves, professor of clinical cancer pharmacology and oncology at the University of Leeds, said the findings show that eribulin can lead to a "substantial improvement" in women's survival rates.
He pointed out that, while the drug was previously only available for women who had undergone several rounds of chemotherapy, the EU has now also approved it for those who have not received as much treatment.
The findings of the study were presented at the National Cancer Research Institute's cancer conference in Liverpool.
28 February 2020
From tulip-filled trips to rose-tinged rests, these destinations are the perfect way to see in the new season.
[more...]
04 January 2021
Join us on a journey to Ancient Greece to discover more about history's most revered statue.
Head north for a light show like no other. Discover how you can see the Northern Lights for yourself.
Discover more about the magnificent waterfall perched on the border of Zambia and Zimbabwe.
10 December 2020
Don't sleep on the world's most impressive dormant volcano.
A destination that stands head and shoulders above the rest.
19 November 2020
Take a tour of one of South America's most captivating natural landscapes.
Discover the hidden depths of the world's most recognisable desert gorge.
It's the question on everyone's mind right now - unfortunately, there's still no easy answer...
Discover why planes are more hygienic than you might think.
Dive into Queensland's colourful coral.
02 November 2020
With the global travel industry slowly getting back on its feet, it's a great time for holiday bargain hunters. Here are our top tips for 2021.